{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:23:32Z","timestamp":1791393812064,"version":"4.3.3"},"reference-count":53,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1038\/ajg.2011.355","type":"journal-article","created":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T09:03:49Z","timestamp":1320138229000},"page":"28-35","source":"Crossref","is-referenced-by-count":235,"title":["The Efficacy and Safety of Rifaximin for the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis"],"prefix":"10.14309","volume":"107","author":[{"given":"Stacy B","family":"Menees","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monthira","family":"Maneerattannaporn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyungjin Myra","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D","family":"Chey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210210","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1053\/j.gastro.2005.11.061","article-title":"Functional bowel disorders.","volume":"130","author":"Longstreth","year":"2006","journal-title":"Gastroenterology"},{"key":"R2-10-20210210","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/0016-5085(91)90717-Y","article-title":"Epidemiology of colonic symptoms and the irritable bowel syndrome.","volume":"101","author":"Talley","year":"1991","journal-title":"Gastroenterology"},{"key":"R4-10-20210210","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1023\/A:1018889318063","article-title":"Differences between individuals with self-reported irritable bowel syndrome (IBS) and IBS-like symptoms.","volume":"42","author":"Hahn","year":"1997","journal-title":"Dig Dis Sci"},{"key":"R5-10-20210210","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/BF01303162","article-title":"US householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact.","volume":"38","author":"Drossman","year":"1993","journal-title":"Dig Dis Sci"},{"key":"R6-10-20210210","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1111\/j.1572-0241.2000.03192.x","article-title":"A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome.","volume":"95","author":"Saito","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"R7-10-20210210","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1111\/j.1572-0241.2001.03961.x","article-title":"Gender-related differences in IBS symptoms.","volume":"96","author":"Lee","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"R8-10-20210210","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1080\/003655201750153476","article-title":"Quality of life in patients with irritable bowel syndrome seen in referral centers versus primary care: the impact of gender and predominant bowel pattern.","volume":"36","author":"Simren","year":"2001","journal-title":"Scand J Gastroenterol"},{"key":"R10-10-20210210","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1111\/j.1365-2036.2005.02463.x","article-title":"Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact.","volume":"21","author":"Hungin","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"R11-10-20210210","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/0016-5085(95)90738-6","article-title":"Medical costs in community subjects with irritable bowel syndrome.","volume":"109","author":"Talley","year":"1995","journal-title":"Gastroenterology"},{"key":"R12-10-20210210","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/0016-5085(95)90773-4","article-title":"Irritable bowel syndrome: a multibillion-dollar problem.","volume":"109","author":"Longstreth","year":"1995","journal-title":"Gastroenterology"},{"key":"R13-10-20210210","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1053\/gast.2001.21908","article-title":"Management of the irritable bowel syndrome.","volume":"120","author":"Camilleri","year":"2001","journal-title":"Gastroenterology"},{"key":"R14-10-20210210","doi-asserted-by":"crossref","first-page":"907","DOI":"10.4065\/75.9.907","article-title":"3rd GR, Zinsmeister AR, Talley V et al. Familial association in adults with functional gastrointestinal disorders.","volume":"75","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"R15-10-20210210","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1126\/science.1078546","article-title":"COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor.","volume":"299","author":"Zubieta","year":"2003","journal-title":"Science"},{"key":"R16-10-20210210","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1136\/gut.2003.035451","article-title":"Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women.","volume":"53","author":"Yeo","year":"2004","journal-title":"Gut"},{"key":"R17-10-20210210","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1136\/gut.2004.039826","article-title":"Is there a SERT-ain association with IBS?","volume":"53","author":"Camilleri","year":"2004","journal-title":"Gut"},{"key":"R19-10-20210210","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1053\/bega.1999.0034","article-title":"Disturbances in small bowel motility.","volume":"13","author":"Quigley","year":"1999","journal-title":"Baillieres Best Pract Res Clin Gastroenterol"},{"key":"R20-10-20210210","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1007\/BF01296097","article-title":"Intestinal motility in irritable bowel syndrome: is IBS a motility disorder? Part 1. Definition of IBS and colonic motility.","volume":"38","author":"McKee","year":"1993","journal-title":"Dig Dis Sci"},{"key":"R21-10-20210210","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1007\/BF01296098","article-title":"Intestinal motility in irritable bowel syndrome: is IBS a motility disorder? Part 2. Motility of the small bowel, esophagus stomach, gall-bladder.","volume":"38","author":"McKee","year":"1993","journal-title":"Dig Dis Sci"},{"key":"R22-10-20210210","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0016-5085(95)90267-8","article-title":"Altered rectal perception is a biological marker of patients with irritable bowel syndrome.","volume":"109","author":"Mertz","year":"1995","journal-title":"Gastroenterology"},{"key":"R23-10-20210210","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1572-0241.2000.01677.x","article-title":"Correlation of symptom criteria with perception thresholds during rectosigmoid distension in irritable bowel syndrome patients.","volume":"95","author":"Schmulson","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"R24-10-20210210","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/gut.48.1.20","article-title":"An exaggerated sensory component of the gastrocolonic response in patients with irritable bowel syndrome.","volume":"48","author":"Simren","year":"2001","journal-title":"Gut"},{"key":"R25-10-20210210","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jpsychores.2008.02.018","article-title":"Brain imaging of visceral functions in healthy volunteers and IBS patients.","volume":"64","author":"Rapps","year":"2008","journal-title":"J Psychosom Res"},{"key":"R26-10-20210210","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1523\/JNEUROSCI.2500-07.2008","article-title":"Reduced brainstem inhibition during anticipated pelvic visceral pain correlates with enhanced brain response to the visceral stimulus in women with irritable bowel syndrome.","volume":"28","author":"Berman","year":"2008","journal-title":"J Neurosci"},{"key":"R27-10-20210210","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1053\/gast.2002.33579","article-title":"Activation of the mucosal immune system in irritable bowel syndrome.","volume":"122","author":"Chadwick","year":"2002","journal-title":"Gastroenterology"},{"key":"R28-10-20210210","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1053\/gast.2002.37059","article-title":"Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome.","volume":"123","author":"Tornblom","year":"2002","journal-title":"Gastroenterology"},{"key":"R29-10-20210210","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/gut.2006.100594","article-title":"Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum.","volume":"56","author":"Guilarte","year":"2007","journal-title":"Gut"},{"key":"R30-10-20210210","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.cgh.2009.06.031","article-title":"Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis.","volume":"7","author":"Ford","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R31-10-20210210","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1007\/s10620-010-1276-4","article-title":"Abnormal breath testing in IBS: a meta-analysis.","volume":"55","author":"Shah","year":"2010","journal-title":"Dig Dis Sci"},{"key":"R32-10-20210210","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1136\/gut.2006.108712","article-title":"Small intestinal bacterial overgrowth in patients with irritable bowel syndrome.","volume":"56","author":"Posserud","year":"2007","journal-title":"Gut"},{"key":"R33-10-20210210","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0016-5085(11)60617-3","article-title":"Small Bowel Culture Confirms the Presence of Small Intestinal Bacterial Overgrowth in a Subset of IBS Subjects.","volume":"140","author":"Pyleris","year":"2011","journal-title":"Gastroenterology"},{"key":"R34-10-20210210","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1471-230X-9-95","article-title":"Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers.","volume":"9","author":"Krogius-Kurikka","year":"2009","journal-title":"BMC Gastroenterol"},{"key":"R35-10-20210210","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1053\/j.gastro.2007.04.005","article-title":"The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects.","volume":"133","author":"Kassinen","year":"2007","journal-title":"Gastroenterology"},{"key":"R36-10-20210210","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s10620-009-0934-x","article-title":"A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome.","volume":"55","author":"Codling","year":"2010","journal-title":"Dig Dis Sci"},{"key":"R37-10-20210210","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.femsim.2004.08.009","article-title":"Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndromea longitudinal study in IBS and control subjects.","volume":"43","author":"Matto","year":"2005","journal-title":"FEMS Immunol Med Microbiol"},{"key":"R38-10-20210210","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.gtc.2010.12.012","article-title":"Food: the forgotten factor in the irritable bowel syndrome.","volume":"40","author":"Eswaran","year":"2011","journal-title":"Gastroenterol Clin North Am"},{"key":"R40-10-20210210","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s10620-006-9104-6","article-title":"Neomycin improves constipation-predominant irritable bowel syndrome in a fashion that is dependent on the presence of methane gas: subanalysis of a double-blind randomized controlled study.","volume":"51","author":"Pimentel","year":"2006","journal-title":"Dig Dis Sci"},{"key":"R41-10-20210210","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1004409","article-title":"Rifaximin therapy for patients with irritable bowel syndrome without constipation.","volume":"364","author":"Pimentel","year":"2011","journal-title":"N Engl J Med"},{"key":"R43-10-20210210","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1572-0241.2006.00458.x","article-title":"A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence.","volume":"101","author":"Sharara","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R44-10-20210210","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jinf.2004.05.019","article-title":"Rifaximina novel antimicrobial for enteric infections.","volume":"50","author":"Huang","year":"2005","journal-title":"J Infect"},{"issue":"Suppl 1","key":"R45-10-20210210","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000089776","article-title":"Experimental and clinical pharmacology of rifaximin, a gastrointestinal selective antibiotic.","volume":"73","author":"Scarpignato","year":"2006","journal-title":"Digestion"},{"key":"R46-10-20210210","doi-asserted-by":"crossref","first-page":"557","DOI":"10.7326\/0003-4819-145-8-200610170-00004","article-title":"The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial.","volume":"145","author":"Pimentel","year":"2006","journal-title":"Ann Intern Med"},{"key":"R47-10-20210210","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials.","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"R48-10-20210210","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1517\/13543780902780175","article-title":"Review of rifaximin as treatment for SIBO and IBS.","volume":"18","author":"Pimentel","year":"2009","journal-title":"Expert Opin Investig Drugs"},{"key":"R49-10-20210210","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1111\/j.1572-0241.2000.03368.x","article-title":"Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome.","volume":"95","author":"Pimentel","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"R50-10-20210210","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1136\/gut.27.1.55","article-title":"Effects of antimicrobial therapy on faecal bulking.","volume":"27","author":"Kurpad","year":"1986","journal-title":"Gut"},{"key":"R51-10-20210210","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s10620-005-2570-4","article-title":"Do interventions which reduce colonic bacterial fermentation improve symptoms of irritable bowel syndrome?","volume":"50","author":"Dear","year":"2005","journal-title":"Dig Dis Sci"},{"key":"R52-10-20210210","first-page":"1582","article-title":"Eradication of small intestinal bacterial overgrowth and oro-cecal transit in diabetics.","volume":"49","author":"Cuoco","year":"2002","journal-title":"Hepatogastroenterology"},{"key":"R53-10-20210210","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00042737-200301000-00012","article-title":"Assessment of orocaecal transit time in different localization of Crohns disease and its possible influence on clinical response to therapy.","volume":"15","author":"Tursi","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R54-10-20210210","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1176\/appi.ajp.157.9.1445","article-title":"Gender differences in treatment response to sertraline versus imipramine in chronic depression.","volume":"157","author":"Kornstein","year":"2000","journal-title":"Am J Psychiatry"},{"key":"R56-10-20210210","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.anaerobe.2009.08.004","article-title":"Rifaximin Redux: treatment of recurrent Clostridium difficile infections with rifaximin immediately post-vancomycin treatment.","volume":"15","author":"Johnson","year":"2009","journal-title":"Anaerobe"},{"key":"R57-10-20210210","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1086\/511870","article-title":"Interruption of recurrent Clostridium difficile-associated diarrhea episodes by serial therapy with vancomycin and rifaximin.","volume":"44","author":"Johnson","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R58-10-20210210","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1128\/AAC.01623-06","article-title":"In vitro activities of 15 antimicrobial agents against 110 toxigenic clostridium difficile clinical isolates collected from 1983 to 2004.","volume":"51","author":"Hecht","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"R59-10-20210210","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jinf.2010.11.004","article-title":"Rifaximin intake leads to emergence of rifampin-resistant staphylococci.","volume":"62","author":"Valentin","year":"2011","journal-title":"J Infect"}],"container-title":["American Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ajg2011355.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2011355","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2011355.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.ovid.com\/00000434-201201000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:37:18Z","timestamp":1786541838000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000434-201201000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1038\/ajg.2011.355","relation":{},"ISSN":["0002-9270"],"issn-type":[{"value":"0002-9270","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}